Transitioning from Pandemic to Endemic
According to experts, the COVID-19 pandemic is expected to transition into an endemic phase by 2022. This transformation will be facilitated by the increasing rates of vaccination and advancements in COVID antiviral medications. As the virus becomes endemic, its severity is projected to decrease, and it will become a regular part of our daily lives, much like various strains of influenza. Although COVID will still pose a threat, it will no longer have the same level of control over our individual and societal actions. Instead, it is likely that populations will need to adopt precautionary measures during specific periods of the year when illnesses tend to peak, such as the colder months.
The Dangers of Variants
When it comes to viral mutations, there is often a trade-off between lethality and infectiousness. A virus that is too deadly may struggle to spread easily as its victims succumb to the illness. Conversely, a virus that can persist in a population for a prolonged period of time has the potential to infect a larger number of hosts.
However, it is important not to assume that this trend always holds true. There is always a possibility for a variant to possess both high lethality and infectiousness, which can pose a significant threat. As a result, much of the ongoing research for COVID vaccines and treatments is focused on developing protection against these potential variants.